Oxa-noribogaine
| Clinical data | |
|---|---|
| Other names | Oxanoribogaine; Oxa-noriboga; 16-Oxanoribogaine; Furanyl-noribogaine; 12-Hydroxy-16-oxaibogamine; 16-Oxaibogamin-12-ol |
| Drug class | κ-Opioid receptor agonist |
| Identifiers | |
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C19H23NO2 |
| Molar mass | 297.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Oxa-noribogaine is an atypical κ-opioid receptor agonist of the "oxa-iboga" family and a synthetic benzofuran analogue of noribogaine. Although it still binds to hERG with similar avidity as noribogaine, it appears to be devoid of the proarrhythmic side effects of noribogaine.